Angiostatin-induced inhibition of endothelial cell proliferation/apoptosis is associated with the down-regulation of cell cycle regulatory protein cdk5

Journal of Cellular Biochemistry

Volumn 91, Issue 2, 2004, Pages 398-409

  Sharma, Meena R ^b   Tuszynski, George P ^c   Sharma, Mahesh C ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c TEMPLE UNIVERSITY   (United States)

Author keywords

Angiostatin; Apoptosis; cdk5; Cycline dependent kinase; Roscovitine

Indexed keywords

ANGIOSTATIN; BASIC FIBROBLAST GROWTH FACTOR; CYCLIN DEPENDENT KINASE 5; ROSCOVITINE; ANGIOGENESIS INHIBITOR; CDK5 PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE; FIBROBLAST GROWTH FACTOR; KINETIN; OLOMOUCINE; PURINE DERIVATIVE;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; AORTA; CATTLE; CELL DIFFERENTIATION; CELL DIVISION; CELL STRAIN 3T3; CYTOLOGY; DRUG EFFECT; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALIA; BOVINAE;

ANGIOGENESIS INHIBITORS; ANGIOSTATINS; ANIMALS; AORTA; APOPTOSIS; CATTLE; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; DOWN-REGULATION; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTORS; KINETIN; MICE; NIH 3T3 CELLS; PURINES;

EID: 5144234547     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.10762     Document Type: Article

References (62)

1. Ahuja HS, Zhu Y, Zakeri Z. 1997. Association of cyclin-dependent kinase 5 and its activator p35 with apoptotic cell death. Dev Genet 21:258-267.
2. Auerbach W, Auerbach R. 1994. Angiogenesis inhibition: A review. Pharmacol Ther 63:265-311.
3. Bajou K, Masson V, Gerard RD, Schmitt PM, Albert V, Praus M, Lund LR, Frandsen TL, Brunner N, Dano K, Fusenig NE, Weidle U, Carmeliet G, Loskutoff D, Collen D, Carmeliet P, Foidart JM, Noel A. 2001. The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol 152:777-784.
4. Biro S, Yu ZX, Fu YM, Smale G, Sasse J, Sanchez J, Ferrans VJ, Casscells W. 1994. Expression and subcellular distribution of basic fibroblast growth factor are regulated during migration of endothelial cells. Circ Res 74:485-494.
5. Bussolino F, Mantovani A, Persico G. 1997. Molecular mechanisms of blood vessel formation. Trends Biochem Sci 22:251-256.
6. Cao Y, Ji RW, Davidson D, Schaller J, Marti D, Sohndel S, McCance SG, O'Reilly MS, Llinas M, Folkman J. 1996. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem 271:29461-29467.
7. Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH. 1997. Mice lacking p35, a neuronal specific activator of cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18:29-42.
8. Claesson-Welsh L, Welsh M, Ito N, Anand-Apte B, Soker S, Zetter B, O'Reilly M, Folkman J. 1998. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci USA 95:5579-5583.
9. Edamatsu H, Gau CL, Nemoto T, Guo L, Tamanoi F. 2000. Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines. Oncogene 19:3059-3068.
10. Engerman RL, Pfaffenbach D, Davis MD. 1967. Cell turnover of capillaries. Lab Invest 17:738-743.
11. Folkman J. 1992. The role of angiogenesis in tumor growth. Semin Cancer Biol 3:65-71.
12. Folkman J. 1993. "Tumor angiogenesis." Philadelphia: Lea and Febiger.
13. Folkman J. 1997. Angiogenesis and angiogenesis inhibition: An overview. Exs 79:1-8.
14. Freeman RS, Estus S, Johnson EM, Jr. 1994. Analysis of cell cycle-related gene expression in postmitotic neurons: Selective induction of cyclin D1 during programmed cell death. Neuron 12:343-355.
15. Griscelli F, Li H, Bennaceur-Griscelli A, Soria J, Opolon P, Soria C, Perricaudet M, Yeh P, Lu H. 1998. Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc Natl Acad Sci USA 95:6367-6372.
16. Hajjar KA, Krishnan S. 1999. Annexin II: A mediator of the plasmin/plasminogen activator system. Trends Cardiovasc Med 9:128-138.
17. Hajjar KA, Menell JS. 1997. Annexin II: A novel mediator of cell surface plasmin generation. Ann NY Acad Sci 811:337-349.
18. Hanahan D, Folkman J. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
19. 1 arrest of endothelial cells through inhibition of cyclin D1. J Biol Chem 277:16464-16469.
20. Harris AL. 1998. Are angiostatin and endostatin cures for cancer? Lancet 351:1598-1599.
21. Hatva E, Kaipainen A, Mentula P, Jaaskelainen J, Paetau A, Haltia M, Alitalo K. 1995. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 146:368-378.
22. Havlicek L, Hanus J, Vesely J, Leclerc S, Meijer L, Shaw G, Strnad M. 1997. Cytokinin-derived cyclin-dependent kinase inhibitors: Synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J Med Chem 40:408-412.
23. Ji WR, Castellino FJ, Chang Y, Deford ME, Gray H, Villarreal X, Kondri ME, Marti DN, Llinas M, Schaller J, Kramer RA, Trail PA. 1998. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. Faseb J 12:1731-1738.
24. Kang HM, Choi KS, Kassam G, Fitzpatrick SL, Kwon M, Waisman DM. 1999. Role of annexin II tetramer in plasminogen activation. Trends Cardiovasc Med 9:92-102.
25. Kornberg L, Earp HS, Parsons JT, Schaller M, Juliano RL. 1992. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem 267:23439-23442.
26. Leventhal PS, Shelden EA, Kim B, Feldman EL. 1997. Tyrosine phosphorylation of paxillin and focal adhesion kinase during insulin-like growth factor-I-stimulated lamellipodial advance. J Biol Chem 272:5214-5218.
27. Lew DJ, Kornbluth S. 1996. Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control. Curr Opin Cell Biol 8:795-804.
28. Lew J, Wang JH. 1995. Neuronal cdc2-like kinase. Trends Biochem Sci 20:33-37.
29. Lucas R, Holmgren L, Garcia I, Jimenez B, Mandriota SJ, Borlat F, Sim BK, Wu Z, Grau GE, Shing Y, Soff GA, Bouck N, Pepper MS. 1998. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood 92:4730-4741.
30. Luo J, Lin J, Paranya G, Bischoff J. 1998. Angiostatin upregulates E-selectin in proliferating endothelial cells. Biochem Biophys Res Commun 245:906-911.
31. Martinez JA, Torres-Negron I, Amigo LA, Banerjee DK. 1999. Expression of Glc3Man9GlcNAc2-PP-Dol is a prerequisite for capillary endothelial cell proliferation. Cell Mol Biol (Noisy-le-grand) 45:137-152.
32. Marushige Y, Marushige K. 1998. Alterations in focal adhesion and cytoskeletal proteins during apoptosis. Anticancer Res 18:301-307.
33. Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP. 1997. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2, and cdk5. Eur J Biochem 243:527-536.
34. Mgbonyebi OP, Russo J, Russo IH. 1999. Roscovitine induces cell death and morphological changes indicative of apoptosis in MDA-MB-231 breast cancer cells. Cancer Res 59:1903-1910.
35. Moser TL, Stack MS, Asplin I, Enghild JJ, Hojrup P, Everitt L, Hubchak S, Schnaper HW, Pizzo SV. 1999. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA 96:2811-2816.
36. Negash S, Wang HS, Gao C, Ledee D, Zelenka P. 2002. cdk5 regulates cell-matrix and cell-cell adhesion in lens epithelial cells. J Cell Sci 115:2109-21117.
37. Nigg EA. 1995. Cyclin-dependent protein kinases: Key regulators of the eukaryotic cell cycle. Bioessays 17:471-480.
38. Nikolic M, Dudek H, Kwon YT, Ramos YF, Tsai LH. 1996. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev 10:816-825.
39. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Cao Y, Moses M, Lane WS, Sage EH, Folkman J. 1994a. Angiostatin: A circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. Cold Spring Harb Symp Quant Biol 59:471-482.
40. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. 1994b. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328.
41. O'Reilly MS, Holmgren L, Chen C, Folkman J. 1996. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 2:689-692.
42. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB. 1996. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology, and perinatal death. Proc Natl Acad Sci USA 93:11173-11178.
43. Ohshima T, Gilmore EC, Longenecker G, Jacobowitz DM, Brady RO, Herrup K, Kulkarni AB. 1999. Migration defects of cdk5(-/-) neurons in the developing cerebellum is cell autonomous. J Neurosci 19:6017-6026.
44. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH. 2001. Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr Rev 22:153-183.
45. Pepper MS. 2001. Extracellular proteolysis and angiogenesis. Thromb Haemost 86:346-355.
46. Risau W. 1997. Mechanisms of angiogenesis. Nature 386:671-674.
47. Schulze-Osthoff K, Risau W, Vollmer E, Sorg C. 1990. In situ detection of basic fibroblast growth factor by highly specific antibodies. Am J Pathol 137:85-92.
48. Schutte B, Nieland L, van Engeland M, Henfling ME, Meijer L, Ramaekers FC. 1997. The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics. Exp Cell Res 236:4-15.
49. Sharma M, Sharma P, Pant HC. 1999. CDK-5-mediated neurofilament phosphorylation in SHSY5Y human neuroblastoma cells. J Neurochem 73:79-86.
50. Sharma MC, Sharma MR, Rothman VL, Tuszynski GP. 2002a. Targeted disruption of annexin II inhibits angiogenesis in vitro and tumor growth in vivo. Proc Am Assoc Cancer Res 43:A894.
51. Sharma P, Veeranna, Sharma M, Amin ND, Sihag RK, Grant P, Ahn N, Kulkarni AB, Pant HC. 2002b. Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J Biol Chem 277:528-534.
52. 1 phase progression: Cycling on cue. Cell 79:551-555.
53. Sherr CJ. 1996. Cancer cell cycles. Science 274:1672-1677.
54. Somerville L, Cory JG. 2000. Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells. Anticancer Res 20:3347-3355.
55. Tarui T, Miles LA, Takada Y. 2001. Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells. J Biol Chem 276:39562-39568.
56. Tarui T, Majumdar M, Miles LA, Ruf W, Takada Y. 2002. Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin. J Biol Chem 277:33564-33570.
57. Troyanovsky B, Levchenko T, Mansson G, Matvijenko O, Holmgren L. 2001. Angiomotin: An angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 152:1247-1254.
58. Tsai LH, Delalle I, Caviness VS, Jr., Chae T, Harlow E. 1994. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature 371:419-423.
59. Tuszynski GP, Sharma MR, Rothman VL, Sharma MC. 2002. Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells. Microvasc Res 64:448-462.
60. Weindel K, Moringlane JR, Marme D, Weich HA. 1994. Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: The key to angiogenesis? Neurosurgery 35:439-448, discussion 448-449.
61. Wu Z, O'Reilly MS, Folkman J, Shing Y. 1997. Suppression of tumor growth with recombinant murine angiostatin. Biochem Biophys Res Commun 236:651-654.
62. Yeh JR, Mohan R, Crews CM. 2000. The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest. Proc Natl Acad Sci USA 97:12782-12787.